Elevated tumor markers for monitoring tumor response to immunotherapy

BACKGROUND: As the immune-related response evaluation criteria in solid tumors (irRECIST) by imaging greatly underestimated the objective response to immunotherapy, we established the response evaluation criteria in solid tumors based on tumor markers (RecistTM) to explore whether RecistTM can compe...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yi, Jiang, Xiaolin, Liu, Yun, Huang, Huan, Xiong, Yanli, Xiao, He, Gong, Kan, Li, Xuemei, Kuang, Xunjie, Yang, Xueqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011015/
https://www.ncbi.nlm.nih.gov/pubmed/35434583
http://dx.doi.org/10.1016/j.eclinm.2022.101381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011015/
https://www.ncbi.nlm.nih.gov/pubmed/35434583
http://dx.doi.org/10.1016/j.eclinm.2022.101381

Ejemplares similares